AFP is also an unsatisfactory marker for the detection of early onset of HCC due to the low sensitivity and high false-positive rate.[4] Consequently, novel effective and reliable tools for detecting and diagnosing the early onset of hepatic carcinoma are highly desirable. This evidence concerns the gene AFP and hepatocellular carcinoma.